B1AJ10 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifqfxcml4abgzl6flp5c5amteylbay4skaswry2kjpjugyw75pex4/metadata.json
IPFS of structure file: 
bafybeihghcqqfn7c7uizkasycvzipi7sx36bfevp7mltjuuevlq2s2zjr4/AF-B1AJ10-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5881B09f2D8e743400698633641fc1cD2Ed2BE6F
First NFT owner address (bech32): 
genesis1tzqmp8ed3e6rgqrfscekg87pe5hd90n0e7l5st
Current NFT ID #450482 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
450482
Accession (UniProt):
B1AJ10
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Ureaplasma parvum serovar 3 (strain ATCC 27815 / 27 / NCTC 11736)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1AJ10 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1AJ10|SYL_UREP2 Leucine--tRNA ligase OS=Ureaplasma parvum serovar 3 (strain ATCC 27815 / 27 / NCTC 11736) OX=505682 GN=leuS PE=3 SV=1 MYNHNKIEKKWQKYWLDNKTFKFVDNPNNPKKFYVLDMFPYPSGKGLHVGHPKGYTATDVISRFKRLNGYDVLHPIGWDAFGLPAEQYALETNNHPHTFTQQNIKIFRKQLQMIGFDFDYDKEVDTTDPQFYQWTQWIFVQLYKHNLAEIQDIDVNWCENLGTVLSNEEVVLNDKNERVSERGGHPVVRKPMKQWVLKIVDYADKLLDGLNEVEFSESLKSLQRNWIGKSIGTSVQFKIKDSLLTLDVFTTRIDTIYGVQYLVVAPEHPILKSITSEQQINVVQSYIEQTKKISDLDRIADTNKTGVFSGAYAINPINQEIIPIWVSDYVLMNFATGAVMGVPAHDERDYAFAKKYALPIKSVIDTKQKLPYAGDGLHINSAMINGLNIKQSQNVLNDYLIKNHLGKKVANYKLRNWIFSRQRYWGEPFPVLFDENNQIKIIEDLPVLLPNLNEFKPSKTGESPLANAQEWLYVEIDGKKYRRETNTMPQWAGSSWYFLAYILKNEDGSYTPLNSEEAKKRFAKWLPVDVYIGGQEHAVLHLLYSRFWHRFLYDIGVVPTKEPFYKVINQGMILGENNEKMSKSKGNVINPDDIIASHGADTLRIYEMFMGPLTASLPWNPDGLDAMRKWLDRVYRLYHNLSELEVVEDLNKLNEEIIIAYHTLIKNYTKAINEQAFNIAISEMMVFVNVLYKNKVINYELLDNFLILLSCYAPHLAEELYSLNHSESVCLQKMPIYDEQKIIAQNITIPIQINGKLKHTINVLRDTNAEELVNLALACEQVKQEIGDQPIKKQIVVVNKIINFVI